AMICUS THERAPEUTICS INC
Industry: Life Sciences ・ $FOLD on Nasdaq
Insider Sale
+$98,763
-0.88%
Shares
Shares Volume: 7,901 Shares
Average Share Price: $12.5
INSIDER
Campbell Bradley L
President and CEO (Director)
reported on Nov 7 2024
traded on Nov 6 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 886,654 |
| PURCHASES/SALES 1Y | 0 / 13 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $114,654.41 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 32 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $237,081.38 |
| COMPANY PREVIOUS TRADES |